2021
DOI: 10.1016/j.jtho.2021.04.007
|View full text |Cite
|
Sign up to set email alerts
|

Long-Term Prognosis of Patients With Resected Adenocarcinoma In Situ and Minimally Invasive Adenocarcinoma of the Lung

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

1
64
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 93 publications
(65 citation statements)
references
References 35 publications
1
64
0
Order By: Relevance
“…In the revised 2021 classification of thoracic tumors, WHO includes AAH and AIS as precursor glandular lesions and classifies MIA and IAC as adenocarcinomas [ 6 ]. In the last decade, large-scale, systematic studies have shown that the long-term postoperative disease-specific survival of AIS and MIA may reach 100% [ 5 , 7 , 8 ]. The good long-term survival of patients with MIA indicates that surgical interventions may not benefit patients with AAH or AIS.…”
Section: Introductionmentioning
confidence: 99%
“…In the revised 2021 classification of thoracic tumors, WHO includes AAH and AIS as precursor glandular lesions and classifies MIA and IAC as adenocarcinomas [ 6 ]. In the last decade, large-scale, systematic studies have shown that the long-term postoperative disease-specific survival of AIS and MIA may reach 100% [ 5 , 7 , 8 ]. The good long-term survival of patients with MIA indicates that surgical interventions may not benefit patients with AAH or AIS.…”
Section: Introductionmentioning
confidence: 99%
“…Causes of GGN include inflammation, pulmonary fibrosis, and the most common early lung adenocarcinoma [ 9 ]. The study found that simple GGNs gradually evolved into lung adenocarcinoma (LA) during long-term follow-up, and lung adenocarcinoma was classified into atypical adenomatous hyperplasia (AAH), adenocarcinoma in situ (AIS), minimally invasive adenocarcinoma (MIA), and invasive adenocarcinoma (IAC) [ 10 ]. Lung adenocarcinoma is more likely to metastasize earlier than lung squamous cell carcinoma, so lung adenocarcinoma has a poor prognosis and needs early diagnosis and treatment [ 11 ].…”
Section: Introductionmentioning
confidence: 99%
“…Different percentages of LC in part‐solid nodules may imply distinctive invasiveness and play an important role in patient outcomes. For example, the patients with adenocarcinoma in situ (AIS) or minimally invasive adenocarcinoma (MIA) had nearly 100% freedom from cancer‐specific death or recurrence 5,9,10 . In previous studies, 11–14 lepidic‐predominant invasive adenocarcinoma also carried more desirable prognosis than adenocarcinomas with other predominant subtypes, and led to more than 90% recurrence‐free survival (RFS).…”
Section: Introductionmentioning
confidence: 99%